DECEMBER 5-9, 2023

HENRY B. GONZALEZ CONVENTION CENTER

SAN ANTONIO, TEXAS

SABCS-2023-cluster-logo-reverse
Media | Gallery | Contact

Home  /   2023 SABCS®  /  Patient Advocates

Patient Advocates

SABCS welcomes attendance by informed patient advocates representing recognized patient advocacy, education & survivor support organizations.

Registration Category & Fees

The patient advocate registration category is reserved exclusively for patient advocates and is not intended for medical professionals. Individuals interested in registering under this category either work or volunteer for national not-for-profit patient advocacy organizations that demonstrate a charitable mission, engage in patient advocacy activities, provide support for people with cancer, have a nonprofessional membership, do not offer CME or scientific programs for professionals.

Individuals registered under this category are not eligible to receive continuing education credit for their attendance.

For advocate program information contact:
Alamo Breast Cancer Foundation
PO Box 780067
San Antonio, TX 78278 

Email: Jerry@alamobreastcancer.org

Category Price
Patient Advocate Fee No Fee


  

Patient Advocate Mentor Sessions

The Alamo Breast Cancer Foundation runs a grassroots advocacy program to eradicate the presence of breast cancer in our society.  Their mission is to end breast cancer by assisting patients, informing policymakers and expanding knowledge through education and community outreach.

Every year, Alamo Breast Cancer Foundation sponsors special mentoring sessions for patient advocates at SABCS. These usually take place 6 PM – 8 PM on Wednesday, Thursday & Friday during the symposium.

Leading experts in the field of breast cancer provide commentary on symposium presentations and respond to advocates’ questions about the relevance of this scientific data.

Click here to view the 2022 Hot Topic Mentor Sessions.

Top

Advocate Program

The 25th Annual Advocate Program is sponsored by Alamo Breast Cancer Foundation (ABCF), a non-profit 501[c]3 organization. This San Antonio-based grassroots advocacy, educational, and support organization was established for women and men with breast cancer and for those concerned about breast cancer issues. ABCF is active locally and nationally.

The 1st Annual Advocate Program was held in 1998, in conjunction with the 21st Annual San Antonio Breast Cancer Symposium, as an educational program specially designed to address the needs of patient advocates and those who support them. 

The administration of this program is handled entirely by Alamo Breast Cancer Foundation. Their 2023 proposal will be mailed to a select list, and we hope you will support their program in addition to the 2023 San Antonio Breast Cancer Symposium.

Contact Information:
Jerry Worden
Alamo Breast Cancer Foundation
PO Box 780067
San Antonio, TX 78278
Email: Jerry@alamobreastcancer.org  

Website Address: www.alamobreastcancer.org

Year Funding Sources # Travel Grants Applications # Travel Grants Awarded Total # Advocate Registration to SABCS®
1998 Glaxo Wellcome Eli Lilly Zeneca 14 14 82
1999 Bristol-Myers Genentech Wyeth-Ayerst 42 30 104
2000 Aventis Genentech AstraZeneca Glaxo Wellcome Pharmacia Oncology 62 50 123
2001 AstraZeneca Aventis Bristol-Meyers Squibb Chroma Vision Eli Lilly Genentech GlaxoSmithKline Pharmacia 52 36 118
2002 AstraZeneca Aventis Bristol-Myers Squibb ChromaVision DakoCytomation Eli Lilly Genentech GlaxoSmithKline Pharmacia 40 28 119
2003 AstraZeneca Pharmaceuticals Bristol Myers Squibb Chromavision DakoCytomation Eli Lilly & Co Genentech Genomic Health GlaxoSmithKline Pfizer 52 37 168
2004 AstraZeneca Pharmaceuticals DakoCytomatic, Inc. Genentech, Inc. Genomic Health, Inc. GlaxoSmithKline Introgen Therapeutics, Inc. Sanofi-Aventis 52 37 168
2005 AstraZeneca Pharmaceuticals Cytyc Eli Lilly & Company Genentech Genomic Health GlaxoSmithKline Introgen Therapeutics Sanofi-Aventis 49 32 201
2006 Avon Foundation NBCC Fund--Best Practices Award AstraZeneca Genentech Genomic Health Eli Lilly Sanofi-Aventis 109 43 199
2007 Abraxis Oncology AstraZeneca Avon Foundation Genentech GlaxoSmithKline Novartis Roche Introgen Therapeutics Sanofi-Aventis Dr. Sharon Wilks 109 42 233
2008 Abraxane-AZ AstraZeneca Avon Foundation Cytori Genentech BioOncology Genomic Health, Inc. GlaxoSmithKline Her2 Support Novartis Roche Sanofi-Aventis Dr. Sharon Wilks 34 32 225
2009 Abraxis BioOncology AstraZeneca Avon Foundation for Women Cytori Therapeutics, Inc Eli Lilly & Co Genentech Genomic Health, Inc GlaxoSmithKline Her2 Support Group Organization National Breast Cancer Coalition Novartis Pharmaceuticals Corp Sanofi-Aventis Dr. Sharon Wilks, MD, FACP Dr. Peter Ravdin, MD, PhD 82 36 235
2010 AACR Abraxis BioOncology Amgen AstraZeneca Avon Foundation for Women Eisai, Inc. Eli Lilly & Co. Genentech GlaxoSmithKline Novartis Pharmaceuticals Corporation Dr. Peter Ravdin, MD, PhD Sanofi-Aventis Dr Sharon Wilks, MD, FACP 107 32 297
2011 AACR Amgen Avon Foundation for Women Boehringer Ingelheim Genentech Genomic Health, Inc. GlaxoSmithKline Julie Ann Carpenter Memorial Fund Novartis Pharmaceuticals Corp Peter Ravdin, MD, PhD Sharon Wilks, MD, FACP Syndax 119 41 298
2012 AACR Amgen Avon Foundation for Women Celgene Corporation Genentech Genomic Health, Inc GlaxoSmithKline Julie Ann Carpenter Memorial Fund Nektar Novartis Pharmaceuticals Corp Peter Ravdin, MD, PhD 68 31 144
2013 AACR Amgen AstraZeneca Avon Foundation for Women Celgene Corporation Genentech Genomic Health Julie Ann Carpenter Memorial Fund Novartis Pharmaceuticals Peter Ravdin, MD, PhD SABCS® Sharon Wilks, MD, FACP 61 23 171
2014 AACR Amgen AstraZeneca Avon Foundation for Women DARA BioSciences Eisai Genentech Genomic Health, Inc Julie Ann Carpenter Memorial Fund NanoString Technologies Nektar Therapeutics Novartis Pharmaceuticals Nuclea Diagnostics Peter Ravdin, MD, PhD Pfizer SABCS® Syndax 78 28 229
2015  AACR Amgen Oncology AstraZeneca Pharmaceuticals
Avon Foundation for Women Eisai Inc. Genentech BioOncology
Genomic Health, Inc. Julie Ann Carpenter Memorial Fund
NanoString Technologies Navidea Biopharmaceuticals Nektar Therapeutics Novartis Oncology Recycledman Foundation SABCS® Susan G. Komen Syndax Pharmaceuticals 		 71  28 196
2016  AACR Amgen Oncology AstraZeneca Pharmaceuticals
Avon Foundation for Women Biotheranostics, Inc. Cascadian Therapeutics Eisai Genentech BioOncology Genomic Health Julie Ann Carpenter Memorial Fund Lumicell
M-3 Health Communications NanoString Technologies
Nektar Therapeutics Novartis Oncology Pfizer The Recycledman Foundation Syndax Pharmaceuticals SABCS® Susan G. Komen  		  63  34 180 
 2017 AACR Avon Foundation for Women Biotheranostics, Inc. The Joe W. and Dorothy Dorsett Brown Foundation Cascadian Therapeutics Eisai Genentech BioOncology Genomic Health Immunomedics Julie Ann Carpenter Memorial Fund Merck NanoString Technologies Nektar Therapeutics Novartis Oncology Pfizer, Inc.  The Recycled Man Foundation Seno Medical Instruments, Inc. Syndax Pharmaceuticals, Inc.  73   31 222 
2018  AACR Arcus BioSciences Biotheranostics, Inc Joe W and Dorothy Dorsett Brown Foundation Celgene Eisai  Elekta Genentech Bio Oncology Genomic Health, Inc Julie Ann Carpenter Memorial Fund Merck & Co Inc NanoString Technologies Nektar Therapeutics Novartis Oncology Pfizer, Inc the Recycledman Foundation San Antonio Breast Cancer Symposium (in kind) Seattle Genetics Seno Medical Instruments, Inc Syndax Pharmaceuticals, Inc Theresa's Foundation  61 25 163 
2019  Agendia AACR SSP
 The Joe W and Dorothy Dorsett Brown Foundation
Eisai, Inc Genentech BioOncology Genomic Health
Julie Ann Carpenter Memorial Fund Mylan
Nektar Therapeutics Novartis Oncology Pfizer, Inc
The Recycled Man Foundation Sanofi-Genzyme
San Antonio Breast Cancer Symposium (in kind) Seattle Genetics Syndax Pharmaceuticals Theresa's Foundation VisionRT 
  57  26  248
2020  N/A  N/A N/A  348
2021   N/A  N/A N/A  304 
Top